Feet Cooling As a Preventive Strategy against Chemotherapy-Induced Peripheral Neuropathy in Advanced Breast Cancer Patients: A Randomized Clinical Trial
- 19 October 2025
- journal article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 26 (1) , 5-12
Abstract
No abstract availableKeywords
Funding Information
- Sabzevar University of Medical Sciences (402045)
This publication has 34 references indexed in Scilit:
- Efficacy of Hand Cooling and Compression in Preventing Taxane-Induced NeuropathyJAMA Oncology, 2025
- Cropsi study: Efficacy and safety of cryotherapy and cryocompression in the prevention of chemotherapy-induced peripheral neuropathy in patients with breast and gynecological cancer–A prospective, randomized trialThe Breast, 2024
- Cryotherapy for prevention of chemotherapy induced peripheral neuropathy in breast cancerCritical Reviews in Oncology/Hematology, 2023
- Randomized adaptive selection trial of cryotherapy, compression therapy, and placebo to prevent taxane-induced peripheral neuropathy in patients with breast cancerBreast Cancer Research and Treatment, 2023
- A randomized controlled trial of hand/foot-cooling by hilotherapy to prevent oxaliplatin-related peripheral neuropathy in patients with malignancies of the digestive systemESMO Open, 2023
- Neurophysiopathological Aspects of Paclitaxel-induced Peripheral NeuropathyNeurotoxicity Research, 2022
- Chemotherapy and peripheral neuropathyNeurological Sciences, 2021
- Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathyAnnals of Oncology, 2020
- Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I); an ACCRU trialThe Breast, 2019
- Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 QuestionnaireQuality of Life Research, 2013